International Network of VENous Thromboembolism Clinical Research Networks

HIGHLOW

Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two doses

Registration:

(Nederlands Trial Register) NTR3894
(Clinicaltrials.gov) NCT01828697

Status:

  • Recruiting
  • Seeking sites and collaborators

Design

Open-label RCT comparing two different doses of low-molecular-weight heparin (LMWH) in pregnant patients with a history of previous venous thromboembolism (VTE)

Participating Sites

DTN logo

Lead Network:

DTN
Flag of The Netherlands

Countries:

Belgium, Canada, France, Ireland, Norway, The Netherlands, USA

Lead Investigators

Dr. I.M. Bistervels

i.m.bistervels@amc.uva.nl
Dr. Saskia Middeldorp

Dr. Saskia Middeldorp, MD, PhD

s.middeldorp@amc.uva.nl

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.